Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New therapy with ‘special scaffold’ reverses paralysis in mice

Mice could walk just four weeks after therapy was administered, says study

Vishwam Sankaran
Friday 12 November 2021 05:52 GMT
Comments
Paralysed mouse (left) drags its hind legs, compared to a mouse that has regained its ability to move its legs after therapy
Paralysed mouse (left) drags its hind legs, compared to a mouse that has regained its ability to move its legs after therapy (Samuel I Stupp Laboratory/Northwestern University)

Your support helps us to tell the story

This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.

The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.

Help us keep bring these critical stories to light. Your support makes all the difference.

Scientists have developed a novel therapy that promotes recovery from spinal cord injury and reverses paralysis in mice, allowing them to walk again within weeks of treatment.

In the research published in the journal Science on Thursday, scientists administered a single injection to tissues surrounding the spinal cords of paralysed mice. Just four weeks later, the rodents could walk again.

The therapy, administered in the form of a gel, works by organising molecules at the injury site into a complex network of nanofibers mimicking the natural matrix found in all tissues that play a major role in wound healing and cell to cell communication, the study noted.

This gel tunes the motion of molecules at the injury sites, enabling them to find and properly engage with constantly moving receptors on cells, said the researchers, including those from Northwestern University in the US.

“The key innovation in our research, which has never been done before, is to control the collective motion of more than 100,000 molecules within our nanofibers,” study co-author Samuel I Stupp from Northwestern University said.

One of the challenges in administering wound healing drugs, the scientists said, is that the receptors sticking out of nerve cells and other types of cells constantly moves around.

The novel gel fine-tunes the motion of molecules which “move, ‘dance’ or even leap temporarily out of these structures”, enabling them to connect more effectively with receptors, Dr Stupp explained.

“Given that cells themselves and their receptors are in constant motion, you can imagine that molecules moving more rapidly would encounter these receptors more often,” he said. “If the molecules are sluggish and not as ‘social’, they may never come into contact with the cells.”

When the molecules connect to the receptors, they trigger two cascading signals critical to spinal cord healing.

One of the signals prompts the regeneration of long tails of the spinal cord’s nerve cells, whose damage often results in the loss of feeling in the body or even paralysis.

By repairing these nerve cell tails – called axons – the communication between the body and brain can be increased, the scientists added.

The second signal, the scientists said, causes the proliferation of other types of cells around the nerves, which promotes the regrowth of lost blood vessels feeding neurons and critical cells for tissue repair.

One of the challenges with using the body’s natural proteins as drugs is that they degrade very fast before they induce the desired biological responses, the researchers said.

But in the new therapy, by acting like a natural scaffold, the molecules are able to last longer and promote nerve regeneration.

“Our synthetic signals are short, modified peptides that — when bonded together by the thousands — will survive for weeks to deliver bioactivity. The end result is a therapy that is less expensive to produce and lasts much longer,” Dr Zaida Álvarez, the study’s first author and former research assistant professor in Dr Stupp’s laboratory, noted.

With further studies and clinical trials, the scientists believe that the new therapy could be used to prevent paralysis after major trauma such as automobile accidents, falls, sports accidents and gunshot wounds, as well as from diseases.

“For decades, this has remained a major challenge for scientists because our body’s central nervous system, which includes the brain and spinal cord, does not have any significant capacity to repair itself after injury or after the onset of a degenerative disease,” Dr Stupp said.

The underlying discovery of “dancing molecules,” the scientists added, can also be applied to other therapies and targets.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in